Cue Biopharma, Inc.
CUE· Nasdaq
Released Aug 9, 2021, after the close
10-Q filed Aug 9, 2021, 40 days after period end · 0001564590-21-042619
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $2.74M | $1.08M | $1.06M | $172.00K |
| Net Income | -$10.28M | -$10.83M | -$9.52M | -$7.30M |
| EPS Diluted | -$0.33 |
Cue Biopharma, Inc. · CIK 1645460 · Engraved from SEC EDGAR
| -$0.38 |
| -$0.46 |
| -$0.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.